Latest news
Loading news…
Medeon Biodesign (TPEx: 6499) is a publicly traded company .
Medeon Biodesign was acquired by Medeologix in 2022.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Investments
2
Monthly Visits
Available in Pro Contacts
5
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Investor Activity
- Investments
- 2
- Lead investments
- 2
- Portfolio orgs
- 2
- Diversity investments
- 1
Company Info
- Org types
- company, investor
- HQ
- Taipei, T'ai-pei, Taiwan
Signals & Scores
- Trend (7d)
- -0.1
- Trend (30d)
- -0.4
- Trend (90d)
- -0.5
Investments by Medeon Biodesign
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Medeon Biodesign
Sr. Director of Research and Development
5
professional contacts at Medeon Biodesign
Contact execs at Medeon Biodesign →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Medeon Biodesign
Loading news…
FAQs about Medeon Biodesign
People who checked this page also checked these
Browse the full Acquirezy directory.